<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bloodjour</journal-id><journal-title-group><journal-title xml:lang="ru">Гематология и трансфузиология</journal-title><trans-title-group xml:lang="en"><trans-title>Russian journal of hematology and transfusiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0234-5730</issn><issn pub-type="epub">2411-3042</issn><publisher><publisher-name>ООО Издательский дом «Практика»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.35754/0234-5730-2023-68-1-8-20</article-id><article-id custom-type="elpub" pub-id-type="custom">bloodjour-428</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Показатели заболеваемости и смертности от злокачественных новообразований лимфоидной и кроветворной тканей в когорте работников, подвергшихся хроническому облучению</article-title><trans-title-group xml:lang="en"><trans-title>Incidence and mortality rates of tumors of the hematopoietic and lymphoid tissues in a cohort of workers chronically exposed to ionizing radiation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6954-2674</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Азизова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Azizova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тамара Васильевна Азизова, кандидат медицинских наук, главный научный сотрудник, заместитель директора по науке, заведующая отделом</p><p>клинический отдел</p><p>456783</p><p>Челябинская обл.</p><p>Озерск</p></bio><bio xml:lang="en"><p>Tamara V. Azizova, Cand. Sci. (Med.), Chief Researcher, Deputy Director, Head of Department</p><p>Clinical Department</p><p>456783</p><p>Chelyabinsk region</p><p>Ozyorsk</p></bio><email xlink:type="simple">clinic@subi.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0410-5048</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брагин</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bragin</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгений Викторович Брагин, научный сотрудник</p><p>456783</p><p>Челябинская обл.</p><p>Озерск</p></bio><bio xml:lang="en"><p>Evgeny V. Bragin, Researcher</p><p>456783</p><p>Chelyabinsk region</p><p>Ozyorsk</p></bio><email xlink:type="simple">clinic@subi.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2755-6282</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Банникова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bannikova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Владимировна Банникова, научный сотрудник</p><p>456783</p><p>Челябинская обл.</p><p>Озерск</p></bio><bio xml:lang="en"><p>Maria V. Bannikova, Researcher</p><p>456783</p><p>Chelyabinsk region</p><p>Ozyorsk</p></bio><email xlink:type="simple">clinic@subi.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1806-9922</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьева</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoryeva</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евгения Сергеевна Григорьева, научный сотрудник</p><p>456783</p><p>Челябинская обл.</p><p>Озерск</p></bio><bio xml:lang="en"><p>Evgeniya S. Grigoryeva, Researcher</p><p>456783</p><p>Chelyabinsk region</p><p>Ozyorsk</p></bio><email xlink:type="simple">clinic@subi.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4922-3742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коробкин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Korobkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Владимирович Коробкин, кандидат медицинских наук, главный внештатный гематолог Министерства здравоохранения Челябинской области, заведующий отделением</p><p>отделение гематологии</p><p>454048</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Aleksandr V. Korobkin, Cand. Sci. (Med.), Chief Freelance Hematologist of  the Ministry of Health of the Chelyabinsk Region, Head of the Department</p><p>Department of Hematology</p><p>454048</p><p>Chelyabinsk</p></bio><email xlink:type="simple">clinic@subi.su</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУН «Южно-Уральский институт биофизики» ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Southern Urals Biophysics Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Челябинская областная клиническая больница»; АНО «Челябинское региональное гематологическое общество»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk Regional Clinical Hospital; Chelyabinsk Regional Hematological Society</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>05</month><year>2023</year></pub-date><volume>68</volume><issue>1</issue><fpage>8</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Азизова Т.В., Брагин Е.В., Банникова М.В., Григорьева Е.С., Коробкин А.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Азизова Т.В., Брагин Е.В., Банникова М.В., Григорьева Е.С., Коробкин А.В.</copyright-holder><copyright-holder xml:lang="en">Azizova T.V., Bragin E.V., Bannikova M.V., Grigoryeva E.S., Korobkin A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.htjournal.ru/jour/article/view/428">https://www.htjournal.ru/jour/article/view/428</self-uri><abstract><p>   Введение. Риск заболеваемости злокачественными новообразованиями лимфоидной и кроветворной тканей (ЗНО ЛиКТ) в группах лиц, подвергшихся острому облучению, повышен. Однако количество работ, посвященных влиянию хронического облучения на возникновение злокачественных новообразований системы крови, невелико.   Цель — оценить показатели заболеваемости и смертности от ЗНО ЛиКТ в когорте работников, подвергшихся профессиональному хроническому облучению.   Материалы и методы. Изучены показатели заболеваемости и смертности от ЗНО ЛиКТ в когорте работников предприятия атомной промышленности, нанятых в период 1948–1982 гг. и наблюдавшихся до конца 2018 г. (22 377 работников). Все работники изучаемой когорты в процессе профессионально-производственной деятельности подвергались внешнему и / или внутреннему облучению. В изучаемой когорте работников были идентифицированы 186 случаев и 123 смерти (основная причина) от ЗНО ЛиКТ за весь период наблюдения (1948–2018 гг.).   Результаты. «Грубые» показатели заболеваемости и смертности от ЗНО ЛиКТ у работников изучаемой когорты зависели от пола, достигнутого возраста работников и календарного периода наблюдения. Стандартизованные показатели заболеваемости и смертности у мужчин были статистически значимо выше по сравнению с женщинами.Стандартизованный показатель заболеваемости ЗНО ЛиКТ (на 1000 человеко-лет наблюдения) у мужчин составил 0,36 ± 0,03, у женщин — 0,23 ± 0,04, а смертности — 0,16 ± 0,02 и 0,09 ± 0,02 соответственно.   Заключение. Выявлены статистически значимые тенденции увеличения показателей заболеваемости хроническими лейкозами и лимфомами.</p></abstract><trans-abstract xml:lang="en"><p>   Introduction. Individuals acutely exposed to ionizing radiation demonstrated an increased risk of incidence of malignant neoplasms of the hematopoietic and lymphoid tissues (HLTT). Meanwhile papers describing the impact of chronic radiation exposure on the hematopoietic system are sparse.Aim — to assess incidence and mortality rates for HLTT in a cohort of workers exposed to chronic, occupational ionizing radiation.   Materials and methods. Incidence and mortality rates of HLTT were assessed for workers of a nuclear industrial enterprise who had been hired at the facility from 1948–1982 and followed up until the end of 2018 (22,377 workers). All workers of the study cohort were externally and/or internally exposed to ionizing radiation during occupational industrial activities. In the studied cohort of workers, 186 cases and 123 deaths (as a main cause) from HLTT were registered throughout the entire follow-up period (1948–2018).   Results. Crude incidence and mortality rates of HLTT in workers of the study cohort were associated with sex, attained age of workers and calendar follow-up period. Standardized incidence and mortality rates for males were significantly higher compared to females. The standardized HLTT incidence rates (per 1000 person-years of observation) were 0.36 ± 0.03 in males and 0.23 ± 0.04 in females while the standardized HLTT mortality rates were 0.16 ± 0.02 in males and 0.09 ± 0.02 in females.   Conclusions. The study revealed significant increasing trends for incidence rates of chronic leukemia and lymphoma by the end of the follow-up period (31. 12. 2018).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>злокачественные новообразования лимфоидной и кроветворной тканей</kwd><kwd>гемобластозы</kwd><kwd>острые лейкозы</kwd><kwd>хронические лейкозы</kwd><kwd>показатели</kwd><kwd>заболеваемость</kwd><kwd>смертность</kwd><kwd>хроническое облучение</kwd><kwd>когорта работников ПО «Маяк»</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tumors of lymphoid and hematopoietic tissues</kwd><kwd>hemoblastosis</kwd><kwd>acute leukemia</kwd><kwd>chronic leukemia</kwd><kwd>rates</kwd><kwd>incidence</kwd><kwd>mortality</kwd><kwd>chronic radiation exposure</kwd><kwd>Mayak Production Association worker cohort</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study had no sponsorship</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization Global Health Observatory Data Repository, Mortality and Global Health Estimates 2012. URL: https://apps.who.int/gho/data.</mixed-citation><mixed-citation xml:lang="en">World Health Organization Global Health Observatory Data Repository, Mortality and Global Health Estimates 2012. URL: https://apps.who.int/gho/data.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Clement C.H., Stewart F.A., Akleyev A.V., et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs — threshold doses for tissue reactions in a radiation protection context. Ann ICRP. 2012; 41(1–2): 1–322. DOI: 10.1016/j.icrp.2012.02.001.</mixed-citation><mixed-citation xml:lang="en">Clement C.H., Stewart F.A., Akleyev A.V., et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs — threshold doses for tissue reactions in a radiation protection context. Ann ICRP. 2012; 41(1–2): 1–322. DOI: 10.1016/j.icrp.2012.02.001.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Akleyev A.V., Kossenko M.M., Startsev N.V. Techa River population: Long term medical follow-up. Br J Radiol. 2002; (Suppl. 26): 32–40.</mixed-citation><mixed-citation xml:lang="en">Akleyev A.V., Kossenko M.M., Startsev N.V. Techa River population: Long term medical follow-up. Br J Radiol. 2002; (Suppl. 26): 32–40.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gidali J. Effects of protracted and chronic irradiation on the haemopoetic system in mouse. Exp Eye Res. 2002; (69): 219–35.</mixed-citation><mixed-citation xml:lang="en">Gidali J. Effects of protracted and chronic irradiation on the haemopoetic system in mouse. Exp Eye Res. 2002; (69): 219–35.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Guskova A.K., Gusev L.A., Okladnikova N.D. Russian concept of chronic radiation disease in man. Br J Radiol. 2002; (Suppl. 26): 19–23.</mixed-citation><mixed-citation xml:lang="en">Guskova A.K., Gusev L.A., Okladnikova N.D. Russian concept of chronic radiation disease in man. Br J Radiol. 2002; (Suppl. 26): 19–23.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Окладникова Н.Д., Кудрявцева Т.И., Беляева З.Д. Плутониевый пневмосклероз, итоги многолетнего медицинского наблюдения. Вопросы радиационной безопасности. 2000; (1): 42–9.</mixed-citation><mixed-citation xml:lang="en">Okladnikova N.D., Kudryavtseva T.I., Belyaeva Z.D. Plutonium pneumosclerosis, conclusions of the continuous medical studies. Voprosy radiatsionnoy bezopasnosti. 2000; (1): 42–9. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Seed T.M., Fritz T.E., Tolle D.V, Jackson W.E. 3rd. Hematopoietic responses under protracted exposures to low daily dose gamma irradiation. Adv Sp Res. 2002; 30(4): 945–55. DOI: 10.1016/s0273-1177(02)00159-x.</mixed-citation><mixed-citation xml:lang="en">Seed T.M., Fritz T.E., Tolle D.V, Jackson W.E. 3rd. Hematopoietic responses under protracted exposures to low daily dose gamma irradiation. Adv Sp Res. 2002; 30(4): 945–55. DOI: 10.1016/s0273-1177(02)00159-x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Azizova T.V., Day R.D., Wald N., et al. The “clinic” medical-dosimetric database of Mayak Production Association workers: Structure, characteristics and prospects of utilization. Health Phys. 2008; 94(5): 449–58. DOI: 10.1097/01.HP.0000300757.00912.a2.</mixed-citation><mixed-citation xml:lang="en">Azizova T.V., Day R.D., Wald N., et al. The “clinic” medical-dosimetric database of Mayak Production Association workers: Structure, characteristics and prospects of utilization. Health Phys. 2008; 94(5): 449–58. DOI: 10.1097/01.HP.0000300757.00912.a2.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zar J.H. Biostatistical Analysis. New Jersey: Prentice Hall; 1999.</mixed-citation><mixed-citation xml:lang="en">Zar J.H. Biostatistical Analysis. New Jersey: Prentice Hall; 1999.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Организация онкологической службы в России (методические рекомендации, пособия для врачей). Часть 2. Под ред. Чиссова В.И., Старинского В.В., Ковалева Б.Н. М.: ФГУ МНИОИ им. П.А. Герцена Росмедтехнологий; 2007.</mixed-citation><mixed-citation xml:lang="en">Organization of oncological service in Russia (guidelines, manuals for physicians). Part 2. Ed. Chissov V.I., Starinsky V.V., Kovalev B.N. Moscow: FGU MNIOI im. P.A. Herzen Rosmedtekhnologii; 2007. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Мерков А.М., Поляков Л.Е. Санитарная статистика (пособие для врачей). М.: Атомиздат; 1975.</mixed-citation><mixed-citation xml:lang="en">Merkov A.M., Polyakov L.E. Sanitary statistics (a manual for doctors). Moscow: Atomizdat; 1975. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Joinpoint Trend Analysis Software. URL: https://surveillance.cancer.gov/joinpoint/.</mixed-citation><mixed-citation xml:lang="en">Joinpoint Trend Analysis Software. URL: https://surveillance.cancer.gov/joinpoint/.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3): 335–51. DOI: 10.1002/(sici)1097-0258(20000215)19:3&lt;335::aid-sim336&gt;3.0.co;2-z.</mixed-citation><mixed-citation xml:lang="en">Kim H.J., Fay M.P., Feuer E.J., Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3): 335–51. DOI: 10.1002/(sici)1097-0258(20000215)19:3&lt;335::aid-sim336&gt;3.0.co;2-z.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lerman P.M. Fitting segmented regression models by grid search. Applied Statistics. 1980; 29(1): 77–84.</mixed-citation><mixed-citation xml:lang="en">Lerman P.M. Fitting segmented regression models by grid search. Applied Statistics. 1980; 29(1): 77–84.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">МКБ-9. Руководство по кодированию заболеваний, травм и причин смерти. Пересмотр 1975 г. Женева: ВОЗ; 1980.</mixed-citation><mixed-citation xml:lang="en">ICD-9. Guidelines for coding diseases, injuries and causes of death. Revision 1975. Geneva: WHO; 1980. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Бондаренко И.А., Мартиросов А.Р., Зингерман Б.В. Гемобластозы на территории России: распространенность и смертность (1999–2007 гг.). Вестник гематологии. 2010; 6(2): 18–9.</mixed-citation><mixed-citation xml:lang="en">Bondarenko I.A., Martirosov A.R., Zingerman B.V. Hemoblastosis in Russia: Prevalence and mortality (1999–2007). Vestnik gematologii. 2010; 6(2): 18–9. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Жигулева Л.Ю., Абдулкадыров К.М. Первичная заболеваемость населения Санкт-Петербурга опухолями кроветворной и лимфоидной тканей в 1990–2011 гг. и прогноз до 2021 г. Клиническая онкогематология. 2015; 8(4): 362–7.</mixed-citation><mixed-citation xml:lang="en">Zhiguleva L.Y., Abdulkadyrov K.M. Primary incidence of hematological malignancies in Saint Petersburg in 1990–2011 and prognosis till 2021. Klinicheskaya onkogematologiya. 2015; 8(4): 362–7. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Бакиров Б.А., Варшавский А.В., Бессмельцев С.С. Динамика заболеваемости гемобластозами в республике Башкортостан (1962–2008 гг.). Российский биомедицинский журнал. 2011; 12: 511–21.</mixed-citation><mixed-citation xml:lang="en">Bakirov B.A., Varshavskiy A.V., Bessmeltsev S.S. The dynamics of hemoblastosis morbidity in the Republic of Bashkortostan (1962–2008). Rossiyskiy biomeditsinskiy zhurnal. 2011; 12: 511–21. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Давыдов М.И., Аксель Е.М. Заболеваемость злокачественными новообразованиями населения России и стран СНГ в 2007 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2009; 20(3 прил. 1): 52–90.</mixed-citation><mixed-citation xml:lang="en">Davydov M.I., Aksel’ E.M. The incidence of malignant neoplasms in the population of Russia and CIS countries in 2007. Vestnik RONC im. N.N. Blohina RAMN. 2009; 20(3 Suppl. 1): 52–90. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Нормы радиационной безопасности (НРБ-99/2009): Санитарно-эпидемиологические правила и нормативы. М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора; 2009.</mixed-citation><mixed-citation xml:lang="en">Radiation safety standards (NRB-99/2009): Sanitary and epidemiological rules and regulations. Moscow: Federal’nyy tsentr gigieny i epidemiologii Rospotrebnadzora; 2009. (In Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
